Helminth Lessons in Inflammatory Bowel Diseases (IBD).

Area of Science:

• Immunology
• Parasitology
• Gastroenterology

Background:

• Helminths are gut-colonizing invertebrates with complex host interactions.
• Exposure to helminths is epidemiologically linked to protection against immune disorders, including inflammatory bowel diseases (IBD).
• Current IBD treatments carry significant risks, highlighting the need for safer alternatives.

Purpose of the Study:

• To explore the therapeutic potential of helminths and their products for immune disorders.
• To investigate the mechanisms by which helminths modulate immune responses relevant to IBD.

Main Methods:

• Review of epidemiological data linking helminth exposure to immune disorder protection.
• Analysis of basic science studies on helminth-host interactions.
• Evaluation of clinical research on helminth-based therapies.

Main Results:

• Helminth colonization can be commensal or symbiotic, not always pathogenic.
• Helminths stimulate protective T helper-2 (Th2) and immune regulatory pathways.
• These pathways are key targets for IBD treatment.

Conclusions:

• Helminths and helminth products represent promising, safe therapeutic candidates for IBD and other immune disorders.
• Further research into helminth-derived therapies could lead to novel treatments for immune-mediated diseases.